Author

B. Berube

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Plant Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Assay:bulk RNA-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Organism:human· 1 Organism:zebrafish· 1

Frequent Co-Authors

T. Parish· 2 shared A. Bhagwat· 1 shared A. Deshpande· 1 shared A. Korkegian· 1 shared A. Scheben· 1 shared A. Siepel· 1 shared B. Roche· 1 shared C. D. Shelton· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

T. Parish

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Teosinte Pollen Drive guides maize diversification and domestication by RNAi

B. Berube, E. Ernst, J. Cahn, B. Roche, C. de Santis Alves, J. Lynn, A. Scheben, A. Siepel, J. Ross-Ibarra, J. Kermicle, R. A. Martienssen

The paper identifies Teosinte Pollen Drive, an RNAi-based gene drive in maize-teosinte hybrids, and shows its role in maize domestication and diversification through linked genetic elements.

bioRxiv · Jul 12, 2023Plant Biology

Inoculum-dependent bactericidal activity of a Mycobacterium tuberculosis MmpL3 inhibitor

B. Berube, A. Deshpande, A. Bhagwat, T. Parish

The paper examines the bactericidal activity of NITD-349, an MmpL3 inhibitor, showing inoculum-dependent kill kinetics and enhanced efficacy when combined with isoniazid.

bioRxiv · Feb 22, 2023 · PreprintMicrobiology

Triazolopyrimidines target aerobic respiration in Mycobacterium tuberculosis

C. D. Shelton, M. B. McNeil, L. Flint, D. Russell, B. Berube, A. Korkegian, Y. Ovechkina, T. Parish

This study identifies triazolopyrimidines as inhibitors of Mycobacterium tuberculosis cytochrome bc1 complex, showing resistance linked to QcrB mutations and efficacy against intracellular bacteria.

bioRxiv · Oct 18, 2021Microbiology